These two cell lines exhibit differential expression of surface IgM, CD22, and CD38, which remains stable over time in culture, with the exception of CD79b and CD38, which decrease in the OSU-CLL line after extended time in cell culture (Figure 1A). The gene discussed is CD79B; the disease is B-cell chronic lymphocytic leukemia.